Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Critical Mineral Executive Order Issued by President Donald Trump (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News 180 Life Sciences Corp ATNF

Technology Information Technology Services
180 Life Sciences Corp. is a clinical-stage biotechnology company focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis. The Company is primary focused on program to treat several inflammatory disorders using anti-TNF (tumor necrosis factor). The Company has three product development platforms: Anti-TNF platform, SCAs platform and a7nAChR... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:ATNF)

180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under NASDAQ Rules

ACCESS Newswire December 27, 2024

180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules

ACCESS Newswire December 12, 2024

180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors

ACCESS Newswire December 4, 2024

180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration

ACCESS Newswire October 31, 2024

180 Life Sciences Corp. Appoints Mr. Jay Goodman to Board of Directors

ACCESS Newswire October 29, 2024

Elray Resources Announces Strategic Sale of Crypto iGaming Technology

GlobeNewswire October 25, 2024

180 Life Sciences Corp. Interim CEO, Blair Jordan, Issues Letter to Stockholders; Provides Update on Newly Acquired Gaming Technology Platform

ACCESS Newswire October 16, 2024

180 Life Sciences Corp. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming Sector

ACCESS Newswire October 9, 2024

180 Life Sciences Corp. - Corporate Updates

ACCESS Newswire October 3, 2024
View More News ››

Opinion & Analysis (NDAQ:ATNF)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ATNF)

ATNF..... just tapped the L.O.D $3.95

Whodda thunk eh ?
Iseneschal - October 17, 2024

RE:ATNF...now over $17

How sweet it is.....$7 per sh profit on that Short position....covered !!!!!
Iseneschal - October 16, 2024

180 Life Sciences Corp. Interim CEO, Blair Jordan, Issues Le

BREAKING NEWS: $ATNF 180 Life Sciences Corp. Interim CEO, Blair Jordan, Issues Letter to Stockholders; Provides Update on Newly Acquired...
whytestocks - October 16, 2024

RE:ATNF...now over $17

ATNF.....now sub $12 Watch this go even lower Love this action!!!
Iseneschal - October 16, 2024

ATNF....now $15

Hehe
Iseneschal - October 16, 2024

ATNF...now over $17

This will be an excellent Short
Iseneschal - October 16, 2024
View more Bullboard ››

NurExone Biologic Inc.

NurExone Biologic Inc.

NurExone Biologic Inc. is a pharmaceutical company. The Company is engaged in developing a platform for biologically guided ...
View More »